Delivery Order SPE2DR25D1034-SPE2DR26FPW2X
- Not listed
- The Defense Logistics Agency awarded a $5,394.54 delivery order to AmerisourceBergen Drug Corp for Briviact 100mg tablets (60 count) on December 4, 2025, with completion expected by December 5, 2025. This non-competitive, firm fixed-price delivery order represents a single pharmaceutical product shipment to support federal medical supply needs. The award was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Briviact 50 mg tablets (60-count package) with a contract ceiling value of $1,085.55. This firm fixed-price delivery order, which is effective through December 5, 2025, represents a non-competitive set-aside award and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $9,077.52 to AmerisourceBergen Drug Corp for Briviact 50 mg tablets (60-count supply) on December 9, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order under its substantial Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Briviact 50 mg tablets (60-count packages) with a ceiling value of $1,868.82. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Briviact 100 mg tablets in a 60-count package with a ceiling value of $2,382.47. This firm fixed-price delivery order, with an ultimate completion date of December 8, 2025, represents a non-competitive, non-set-aside award executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Briviact 100 mg tablets (60-count units) with a ceiling value of $3,267.93. This firm fixed-price delivery order, which is expected to be completed by December 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a $1,859.98 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Briviact 50 mg tablets (60-count packages). This firm fixed-price delivery order represents a non-set-aside, competitively awarded procurement supporting federal medical supply needs. The order is scheduled for completion by August 19, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,857.36 to AmerisourceBergen Drug Corp for Briviact 100 mg tablets (60-count) on November 5, 2025, with completion scheduled for November 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Briviact 50 mg tablets (60-count units) at a ceiling value of $1,055.99. This firm fixed price delivery order, with an ultimate completion date of November 7, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of Briviact 75 mg tablets (60-count units) with a ceiling value of $5,930.33. This is a firm fixed-price delivery order with an ultimate completion date of December 2, 2025, and represents a competitively awarded contract with no set-aside designation. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D1034Indefinite Delivery Contract
- SPE2DR25D1034-SPE2DR26FPW2XDelivery Order
The Defense Logistics Agency awarded a $1,751.10 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Briviact 50 mg tablets in quantities of 60 units. This firm fixed-price delivery order represents a non-competitive award without set-aside designation and is scheduled for completion by December 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued as a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a prime vendor within the DLA's pharmaceutical supply chain, AmerisourceBergen leverages this comprehensive contract vehicle to supply medications, vaccines, medical devices, and specialized healthcare commodities to support military health systems and other federal agencies globally. The current award for Briviact reflects the company's ongoing role in fulfilling tactical pharmaceutical procurement needs for defense and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 12/7/25 |